Summary of opinion: Blincyto, 12/12/2024 Positive

First medicine to treat rare genetic disorder causing cysts and tumours

Summary of opinion: Vocabria, 12/12/2024 Positive

Alofisel withdrawn from the EU market

First treatment recommended for rare progressive lung conditions in children and adolescents

Human medicines European public assessment report (EPAR): Ledaga, chlormethine, Date of authorisation: 03/03/2017, Revision: 10, Status: Authorised

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in Europe - Chapter 1: Registration requirements

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 19 November 2024, 12:30 (CET) to 19 November 2024, 14:30 (CET)

Human medicines European public assessment report (EPAR): Cystadane, betaine anhydrous, Date of authorisation: 14/02/2007, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Isturisa, osilodrostat, Date of authorisation: 09/01/2020, Revision: 7, Status: Authorised